Publication | Closed Access

Laquinimod Treatment Improves Myelination Deficits at the Transcriptional and Ultrastructural Levels in the YAC128 Mouse Model of Huntington Disease

NeuroregenerationMedicineMyelination DeficitsDegenerative DiseaseHuntington DiseaseNeurologyNeuroscienceNeurodegenerationCentral Nervous SystemNeuropathologyLaquinimod TreatmentMolecular NeurobiologySocial SciencesCellular Neurobiology